度伐利尤单抗联合曲美木单抗一线治疗晚期肝细胞癌的成本-效用分析*
陈秋平,邵明义,崔鸿雁,吕兰青,陈晓琦
Cost-effectiveness Analysis of Durvalumab Combined with Tremelimumab in the First-line Treatment of Advanced Hepatocellular Carcinoma
CHEN Qiuping,SHAO Mingyi,CUI Hongyan,LYU Lanqing,CHEN Xiaoqi
医药导报
.
2023, (10): 1492
-1497
.
DOI: 10.3870/j.issn.1004-0781.2023.10.012